doi:10.2337/diabetes.55.03.06.db05-1039 Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ
This activation enhances natural GH pulses without directly supplying exogenous hormone
Integrative function of adrenaline receptors for glucagon-like peptide-1 exocytosis in enteroendocrine L cell line GLUTag
J., Abrahams, N., Mokoena, N
(1999) European Journal of Endocrinology Comprehensive pharmacological characterization confirming ipamorelin selectivity across multiple species and dose ranges, with comparison to GHRP-6 and GHRP-2
Novo Nordisk is currently running two large Phase 3 trials to investigate the effect of GLP-1 drugs on Alzheimer's disease, based on early data suggesting reduced neuroinflammation, improved cognition and function, and enhanced memory, as well as trials in which GLP-1 drugs appeared to substantially reduce dementia rates in diabetes patients